ApprovalTrail

Drug · DIN 02418355

SOVALDI

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since January 6, 2014; first marketed January 6, 2014.
Drug Identification Number (DIN)
02418355
Company (DIN owner)
Gilead Sciences Canada IncMississauga, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Sofosbuvir J05AP08
Class
Human
Record last updated
June 22, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
SOFOSBUVIR400 MG

Notices of Compliance

Health Canada approvals that name this DIN.